Insider · CIK 0001409232
Miriam Kidron
officerdirector
Files at ORMP (ORAMED PHARMACEUTICALS INC.), LFWD (Lifeward Ltd.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +208,125 | - | - | 1,341,263 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +209,291 | - | - | 1,550,554 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -104,000 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -100,000 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -69,999 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -47,000 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -100,000 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -72,000 | - | - | 0 | 17 d ago |
| Mar 30, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | FTax withholding Common Stock | -435,084 | $3.31 | $1.4M | 1,133,138 | Mar 31, 2026 |
| Mar 25, 2026 | LFWD Lifeward Ltd. | AGrant or award Ordinary Shares, no par value per share | +7,657 | $0.00 | $0 | 7,657 | Mar 27, 2026 |
| Mar 17, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +119,558 | $0.00 | $0 | 1,568,222 | Mar 18, 2026 |
| Jan 22, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | MOption exercise Common Stock | +19,000 | $0.00 | $0 | 1,448,664 | Jan 29, 2026 |
| Jan 22, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | MOption exercise Performance Stock Unitsderivative | -19,000 | $0.00 | $0 | 0 | Jan 29, 2026 |
| Jan 14, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | GGift Common Stock | -86,166 | $0.00 | $0 | 1,343,498 | Jan 21, 2026 |
| Dec 31, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +121,331 | $0.00 | $0 | 1,314,664 | Jan 5, 2026 |
| Dec 31, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +115,000 | $0.00 | $0 | 1,429,664 | Jan 5, 2026 |
| Dec 31, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Performance Stock Unitsderivative | +19,000 | $0.00 | $0 | 19,000 | Jan 5, 2026 |
| Feb 11, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +74,000 | $0.00 | $0 | 1,074,666 | Feb 11, 2025 |
| Feb 11, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +52,000 | $0.00 | $0 | 1,126,666 | Feb 11, 2025 |
| Feb 11, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +66,667 | $0.00 | $0 | 1,193,333 | Feb 11, 2025 |
| Jan 2, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +207,000 | - | - | 1,000,666 | Jan 6, 2025 |
| Nov 7, 2024 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +30,000 | - | - | 793,666 | Nov 8, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.